VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tunica Albuginea who wrote (5482)	2/17/1998 9:52:00 AM
From: BigKNY3	Read Replies (1) of 23519

TA : Several friendly questions and comments for you: TA: << One of the retina fellows, doing a retina fellowship, asked me if a retinal ERG ( electroretinogram ) had been done on any of the Viagra patients complaining of visual disturbances/" blue halos'; he said that is the only way to evaluate any retinal damage. I told him, No, that none of the Viagra studies so far had mentioned ERGs; they only did general chemistry profiles.>> Question: PFE has submitted data on over 4,500 patients to the FDA. I have only seen you comment on only one study with 12 patients. Do you really know what was included for the other 4,486 patients? Why jump to conclusions now and develop your own theories until the data is known following the FDA priority review? This information should be readily available prior to the product being available for prescribing.... via published papers and at the AUA meeting in May. TA <<"they had to rush " through Redux because obesity was a " national emergency" and they totally disregard reports of cardiac valve irregularities, and no echocardiograms were done on any of the patients in their phase III study that complained of chest pain. Pill was approved and all this was found out later by physicians in phase IV.>> Question :Are echocardigrams required on all NDA submissions? Do you know if echocardiograms were conducted on Phase III MUSE studies? A correction: Redux valve irregularities were not discovered in Phase IV studies but by individual physician reports requested by the FDA from Phase III investigators. TA << I will be talking with some more ophthalmologists and PhDs doing molecular bioresearch. >> Question: How can we evaluate the quality of your unnamed references? Do they own VVUS stock? Are they affiliated with your hospital pharmacist who considers Pfizer to have "a VERY WEAK DRUG PIPELINE". www3.techstocks.com TA <<More as I get the data.>> Question: You have posted that you think ED investigators may be biased because of their grant relationships with pharmaceutical companies. Given your apparently large financial position in VVUS, do you think you are biased in your evaluation of MUSE and oral ED products? BigKNY3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next